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Background
Congenital scoliosis is a common type of vertebral malformation. Genetic suscep-
tibility has been implicated in congenital scoliosis.
Methods
We evaluated 161 Han Chinese persons with sporadic congenital scoliosis, 166 Han 
Chinese controls, and 2 pedigrees, family members of which had a 16p11.2 dele-
tion, using comparative genomic hybridization, quantitative polymerase-chain-
reaction analysis, and DNA sequencing. We carried out tests of replication using an 
additional series of 76 Han Chinese persons with congenital scoliosis and a multi-
center series of 42 persons with 16p11.2 deletions.
Results
We identified a total of 17 heterozygous TBX6 null mutations in the 161 persons 
with sporadic congenital scoliosis (11%); we did not observe any null mutations in 
TBX6 in 166 controls (P<3.8×10−6). These null alleles include copy-number variants 
(12 instances of a 16p11.2 deletion affecting TBX6) and single-nucleotide variants 
(1 nonsense and 4 frame-shift mutations). However, the discordant intrafamilial 
phenotypes of 16p11.2 deletion carriers suggest that heterozygous TBX6 null muta-
tion is insufficient to cause congenital scoliosis. We went on to identify a common 
TBX6 haplotype as the second risk allele in all 17 carriers of TBX6 null mutations 
(P<1.1×10−6). Replication studies involving additional persons with congenital sco-
liosis who carried a deletion affecting TBX6 confirmed this compound inheritance 
model. In vitro functional assays suggested that the risk haplotype is a hypomorph-
ic allele. Hemivertebrae are characteristic of TBX6-associated congenital scoliosis.
Conclusions
Compound inheritance of a rare null mutation and a hypomorphic allele of TBX6 
accounted for up to 11% of congenital scoliosis cases in the series that we analyzed. 
(Funded by the National Basic Research Program of China and others.)
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Congenital scoliosis, a form of ver-tebral malformation, has an estimated prevalence of approximately 1 in 2000 live 
births.1 It is manifested as a lateral curvature of 
the spine exceeding 10 degrees and results from 
defects in vertebra formation during embryo-
genesis.2,3
Previous evidence in animal models suggested 
that genetic factors contribute to vertebral mal-
formations.3,4 Genetic mutations have been im-
plicated in human congenital scoliosis, but their 
low penetrance highlights the complex molecu-
lar basis of the disorder and hinders molecular 
diagnosis of and genetic counseling for congeni-
tal scoliosis.4,5
The proximal 16p11.2 deletion in humans is 
rare but recurrent, with a population frequency of 
approximately 0.03% worldwide.6 It is a likely 
cause of common diseases, including autism and 
obesity.7-9 Vertebral malformations have been ob-
served in a small proportion of persons with 
16p11.2 copy-number variants (including deletion 
and duplication),10-12 a finding that suggests the 
potential involvement of 16p11.2 copy-number 




We enrolled 237 consecutive Han Chinese persons 
who received a diagnosis of congenital scoliosis 
between October 2010 and June 2014 at Peking 
Union Medical College Hospital (PUMCH). Ances-
try was determined by self-report (see the Methods 
section in the Supplementary Appendix, available 
with the full text of this article at NEJM.org). The 
discovery set consisted of 161 persons with spo-
radic congenital scoliosis (series 1), and we tested 
for replication in an additional series of 76 per-
sons with the disorder (series 2). A clinical diag-
nosis of congenital scoliosis was confirmed by 
radiologic imaging. We excluded persons with 
syndromic diseases.
A total of 166 unrelated Han Chinese persons 
with no evidence of congenital scoliosis or other 
malformations served as population controls. We 
also evaluated 2 Han Chinese pedigrees, family 
members of which carried the 16p11.2 deletion 
and had discordant intrafamilial phenotypes.
For a further replication study, 42 unrelated 
persons with 16p11.2 deletion (series 3) were en-
rolled from multiple centers in the United States 
and China. These persons were initially referred for 
clinical chromosomal microarray testing owing to 
various medical problems.13-15
Cell Culture and Induced Differentiation
The P19CL6 cell line (derived from a mouse em-
bryonic carcinoma) was cultured and differenti-
ated into cardiomyocytes, as described previous-
ly.16 The cells were harvested every 24 hours after 
treatment with dimethyl sulfoxide.17 We also used 
a human induced pluripotent stem cell (hiPSC) 
line that we derived from dermal fibroblasts by 
means of an efficient and integration-free meth-
od.18 The culture of this hiPSC line and its in-
duced differentiation to mesodermal-cell and 
cardiac-cell lineages has been described previ-
ously.19,20 The cells were harvested 24 hours and 
48 hours after differentiation with RPMI–B-27 
medium without insulin.
Analysis of Genotype–Phenotype Correlation
We reviewed the medical records and spinal ra-
diographs of all 237 persons with sporadic con-
genital scoliosis. Vertebral malformations were 
classified as hemivertebra or hypoplasia, segmen-
tation defect, or butterfly vertebra, as defined in a 
previous report.21 Vertebral malformations at more 
than one site in a patient were classified and count-
ed independently according to location.
Study Oversight
This study was approved by the institutional re-
view boards of the PUMCH, Fudan University, the 
Capital Institute of Pediatrics, and the other par-
ticipating institutions. We obtained written in-
formed consent from the participants (those who 
were ≥18 years of age at the time of enrollment) 
or their guardians (for participants who were 
<18 years of age).
Statistical Analysis
Fisher’s exact test was used to assess the differ-
ence in TBX6 mutation or variant frequencies be-
tween the persons with congenital scoliosis and 
controls. The unpaired t-test was used for statis-
tical analysis of the luciferase reporter assays. Pear-
son’s chi-square test was used to assess the differ-
ence in the prevalence of vertebral malformations 
between persons with TBX6-associated congenital 
scoliosis and those with congenital scoliosis but no 
TBX6 nonsynonymous mutation. Odds ratios and 
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95% confidence intervals were calculated. The 
statistical analysis was performed with the use 
of SPSS software, version 15.0 (SPSS). A two-sided 
P value of less than 0.05 was considered to indi-
cate statistical significance.
Further details of the study participants and of 
assays using comparative genomic hybridization 
(CGH), quantitative polymerase chain reaction, 
DNA sequencing of TBX6, haplotyping of TBX6 
variants, and luciferase assays can be found in 
the Supplementary Appendix.
R esult s
Prevalence of 16p11.2 Deletions in Persons 
with Congenital Scoliosis
A genomewide analysis of copy-number variants 
was performed in 20 trios (consisting of a person 
with sporadic congenital scoliosis and two healthy 
parents) with the use of Agilent 1×1M CGH mi-
croarrays. We identified recurrent deletions in 
proximal 16p11.2 (Fig. 1A) in two persons (Pa-
tient XH004 and Patient XH042) (Fig. S1 in the 
Supplementary Appendix). Both of these hetero-
zygous deletions were de novo (i.e., absent in the 
patient’s parents).
Of the remaining 141 persons with sporadic 
congenital scoliosis in series 1, 10 had a hetero-
zygous 16p11.2 deletion (Table 1), whereas none 
of the 166 Han Chinese controls had the deletion 
(12 of 161 persons with congenital scoliosis vs. 
0 of 166 controls, P<0.001 by Fisher’s exact test). 
These findings are consistent with the rarity of 
the 16p11.2 deletion in human populations 
(0.03%).22,23 Remarkably, the prevalence of the 
deletion among persons with sporadic congenital 
scoliosis (12 of 161 persons, 7.5%) was much 
higher than its reported prevalence among per-
sons with autism (0.4 to 0.8%)6,7 or obesity 
(0.7%),8,9 two phenotypes that it is known to 
cause. None of our patients with congenital sco-
liosis were obese. Their detailed neurodevelop-
mental records were not available for us to evalu-
ate symptoms of autism.
Association of TBX6 Loss-of-Function 
Mutations with Congenital Scoliosis
The association of the 16p11.2 deletion with con-
genital scoliosis suggested that a gene related to 
the disorder may be located in the segment of 
DNA that is deleted: of these genes, TBX6 was 
considered to be the best candidate (Fig. 1B).24-26 
Accordingly, we hypothesized that other null or 
loss-of-function mutations (e.g., nonsense, frame-
shift, and essential splice-site variants)27 of TBX6 
cause congenital scoliosis. One heterozygous non-
sense and four heterozygous frame-shift muta-
tions of TBX6 were identified among the patients 
with congenital scoliosis in series 1 (Table 1, and 
Fig. S2 in the Supplementary Appendix). The frame-
shift mutation in Patient XH122 was de novo, 
whereas the status (i.e., de novo or inherited) of the 
other four null mutations is unknown. In con-
trast, we did not observe any null mutations in the 
controls (5 of 161 persons with congenital scolio-
sis vs. 0 of 166 controls, P = 0.03 by Fisher’s exact 
test). These findings suggest an association of 
TBX6 null mutations with congenital scoliosis.
Furthermore, we identified TBX6 missense 
mutations in 7 of 161 persons with congenital 
scoliosis in series 1, a prevalence higher than 
that among the controls (3 of 166 persons) and 
among Han Chinese populations in Beijing and 
in southern China (CHB and CHS populations) 
in the 1000 Genomes Project (1 of 197 persons) 
(Fig. S3 and Tables S1 through S4 in the Supple-
mentary Appendix).22 In a combined analysis, 
the association of TBX6 missense mutations with 
congenital scoliosis was significant (7 of 161 per-
sons with congenital scoliosis vs. 4 of 363 con-
trols, P = 0.04 by Fisher’s exact test). Because mis-
sense mutations could be benign or even confer a 
gain of function, we did not include them in ad-
ditional analyses, although we cannot exclude the 
possibility of a role for them in congenital sco-
liosis.
A Common Risk Haplotype in Null Mutation 
Carriers
Each person with congenital scoliosis in series 1 
who carried a TBX6 mutation was found to have 
only one null mutation (Table 1), which, at face 
value, suggests a simple dominant mode of in-
heritance. However, dominant inheritance is not 
supported by the low penetrance of congenital 
scoliosis in carriers of the 16p11.2 deletion af-
fecting TBX6.10-12 We therefore hypothesized that 
an additional genetic modifier acts in concert with 
TBX6 null mutations to cause congenital scoliosis.
To test this hypothesis, we analyzed two 
pedigrees with an affected member and unaf-
fected members who had the same 16p11.2 dele-
tion. In Pedigree SE1 (Fig. 1C), the proband had 
congenital scoliosis with hemivertebra, whereas 
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the father and sibling had the same deletion but 
did not have congenital scoliosis.12 In Pedigree SE2 
(Fig. 1D), the deletion in the proband was pater-
nally inherited. The radiograph revealed a wedge-
shaped vertebral malformation in the proband 
(Fig. 2); congenital scoliosis was not observed in 
the father.
We did not identify a rare mutation in TBX6, 
other than the deletion itself, in any of the fam-
ily members. However, we did observe a common 
TBX6 haplotype of T-C-A (defined by the nonrefer-
ence alleles of three common single-nucleotide 
polymorphisms [SNPs] — rs2289292, rs3809624, 
and rs3809627, respectively) that cosegregated 
with congenital scoliosis in both pedigrees 
(Fig. 1). Therefore, we further evaluated the 17 
16p11.2
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Genomic Region Affected by Proximal 16p11.2 Deletion
Figure 1. Effect of the 16p11.2 Deletion on TBX6.
Panel A shows the region affected by the proximal 16p11.2 deletion based on the human genome assembly hg19. A 
pair of long direct genomic repeats (shown in orange) can mediate 0.6-Mb recurrent deletions. The genes affected by 
this deletion, including TBX6 (circled), are shown. Panel B shows three common single-nucleotide polymorphisms 
(SNPs) in TBX6. Two SNPs, rs3809624 and rs3809627, are located in the 5′ noncoding region, whereas rs2289292 
is a synonymous SNP in the last exon. Panels C and D show two pedigrees with 16p11.2 deletions (SE1 and SE2). 
Squares denote male pedigree members, circles female pedigree members, solid symbols members with congenital 
scoliosis, and open symbols unaffected members; the probands are indicated by black arrows. The red bracket repre-
sents the deletion allele, and the nonreference alleles of rs2289292, rs3809624, and rs3809627 on the nondeletion 
chromosomes are shown in blue. The slash denotes a deceased family member. NA denotes not available.
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Table 1. Genetic and Clinical Characteristics of Patients with TBX6-Associated Congenital Scoliosis.
Patient No. Sex Age (yr) TBX6 Allele Vertebral Malformation* Other Congenital Malformation





Congenital scoliosis series 1 (discovery)
XH004 F 4 16p11.2 del T-C-A L1 hemivertebra (left) None
XH025 M 3 16p11.2 del T-C-A T11 hemivertebra (left) Rib abnormality (missing left 11th rib)
XH042 M 6 16p11.2 del T-C-A T9 hemivertebra (left) Patent foramen ovale and rib abnormalities 
(missing right 9th and left 12th ribs)
XH141 F 18 16p11.2 del T-C-A T4 hemivertebra (left) Syringomyelia, spina bifida, and rib abnor-
malities (fused left 3rd through 6th ribs)
XH149 F 7 16p11.2 del T-C-A T12 hemivertebra (right) Rib abnormality (missing left 12th rib)
XH186 M 4 16p11.2 del T-C-A T11 hemivertebra (left) Rib abnormality (missing right 11th rib)
XH237 M 13 16p11.2 del T-C-A T12 hemivertebra (left) and L3 
butterfly vertebra
Rib abnormality (missing right 12th rib)
XH265 M 4 16p11.2 del T-C-A L1 hemivertebra (right) None
XH270 M 14 16p11.2 del T-C-A T11 and T12 hemivertebrae 
(left)
Rib abnormalities (missing right 12th rib 
and bifurcation of right 2nd rib)
XH292 F 11 16p11.2 del T-C-A T6 hemivertebra (left) and T12 
wedge vertebra
Rib abnormality (missing right 6th rib)
XH300 M 3 16p11.2 del T-C-A T10 hemivertebra (left) Rib abnormalities (missing right 10th rib 
and bifurcation of right 9th rib)
XH303 M 5 16p11.2 del T-C-A T7 butterfly vertebra and T12 
hemivertebra (left)
Rib abnormality (missing left 12th rib)
XH101 F 7 c.1250_1251insT
frame shift
T-C-A L2 hemivertebra (left) Atrial septal defect and rib abnormalities 
(missing bilateral 12th ribs)
XH122 M 5 c.266_267insC
frame shift
T-C-A Hemivertebra (left) between 
T12 and L1
Rib abnormality (missing right 12th rib)
XH170 M 5 c.704_705insG
frame shift
T-C-A T12 hemivertebra (left) Rib abnormality (missing right 12th rib)
XH286 M 2 c.1169_1170insC
frame shift
T-C-A L2 hemivertebra (left) and T8 
butterfly vertebra
None
XH148 F 16 c.844C→T
(p.R282X)
T-C-A T1 and L3 butterfly vertebrae, 
T4 hemivertebra (right), 
and T7 hemivertebra (left)
None
Congenital scoliosis series 2 (replication)
XR345 F 13 16p11.2 del T-C-A Hemivertebra (left) between 
T12 and L1
None
XR353 M 11 16p11.2 del T-C-A T11 hemivertebra (right) Rib abnormality (missing left 11th rib)
XR402 M 11 16p11.2 del T-C-A C5 hemivertebra (left), T5 
hemivertebra (right), and 
T8 hemivertebra (left)
Rib abnormalities (missing left 5th and 
right 8th ribs)
XR434 F 16 16p11.2 del T-C-A T12 hemivertebra (left) and T9 
butterfly vertebra
None
XR439 F 7 16p11.2 del T-C-A L3 hemivertebra (right) None
XR341 M 2 c.1179_1180delAG
frame shift
T-C-A T12 hemivertebra (right) Rib abnormality (missing left 12th rib)
* C denotes cervical, L lumbar, and T thoracic.
† T-C-A represents the haplotype defined by three common TBX6 single-nucleotide polymorphisms (reference/nonreference): rs2289292 
(C/T), rs3809624 (T/C), and rs3809627 (C/A).
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persons with congenital scoliosis in series 1 who 
had the TBX6 null mutations. All 17 persons car-
ried the T-C-A haplotype at the second TBX6 al-
lele (Table 1). The probability of this coinheri-
tance is P = (44%)17, which is equivalent to 
P<1.1×10−6, where 44% is the frequency of the 
T-C-A haplotype among Han Chinese persons in 
the 1000 Genomes Project (Table S5 in the Sup-
plementary Appendix).22 Our observations sug-
gest a genetic model of TBX6 compound inheri-
tance involving a combination of rare null and 
common risk alleles in the causation of congeni-
tal scoliosis. This model accounts for 17 of 161 
cases of congenital scoliosis (11%) in series 1 
(Table 2).
Replication Studies
We recruited an additional 76 persons with con-
genital scoliosis (series 2) and identified 6 TBX6 
null mutations (Table 1). Again, we observed the 
T-C-A risk haplotype at the second allele in all 
persons with these mutations. The TBX6 com-
pound inheritance model accounts for 6 of 76 cases 
of congenital scoliosis (8%) in series 2 (Table 2).
Furthermore, we enrolled 42 persons with the 
16p11.2 deletion (series 3) from multiple centers 
(Table S6 in the Supplementary Appendix). These 
persons were categorized into three subgroups: 
those with congenital scoliosis (vertebral malfor-
mations), those who had scoliosis without verte-
bral malformations, and those with no evidence 
of scoliosis. This made it feasible to investigate 
whether the hemizygous T-C-A haplotype is as-
sociated with congenital scoliosis in 16p11.2 dele-
tion carriers. In the congenital scoliosis subgroup, 
we identified 5 of 6 persons (83%) as having the 
hemizygous T-C-A haplotype (Table 2). The only 
exception (Patient PT03) was of African ancestry,13 
and the T-C-A haplotype is rare among such per-
sons (prevalence, <1% among Africans, as com-
XH004 XH025 XH042 XH101 XH122 XH141 XH148
XH292 XH300 XH303 XR341 XR345 XR353 XR402
XR434 XR439 BS01 BS19 ET02 SE02 SE02
XH149 XH170 XH186 XH237 XH265 XH270 XH286
Figure 2. Spinal Radiographs in Patients with TBX6-Associated Congenital Scoliosis.
The vertebrae with malformations are indicated by arrows. The patient number is shown above each radiograph.
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pared with 44% among Asians and 33% among 
persons of European descent) (Table S5 in the 
Supplementary Appendix). Patient PT03 had the 
nonreference allele of SNP rs111939223 (present 
in 4% of Yoruba Africans but absent in Asians 
and Europeans), which is located at a predicted 
messenger RNA polyadenylation site of TBX6.28 
Therefore, we cannot exclude the possibility of 
compound inheritance of a TBX6 null mutation 
and an alternative risk haplotype among persons 
of African ancestry in Patient PT03.
In the no-scoliosis subgroup, the T-C-A hap-
lotype was present in only 5 of 30 persons (17%) 
(Table S7 in the Supplementary Appendix). The 
T-C-A risk haplotype was a significant risk factor 
for congenital scoliosis in series 3 (5 of 6 persons 
with congenital scoliosis vs. 5 of 30 persons with-
out scoliosis, P = 0.004 by Fisher’s exact test), which 
further supports the TBX6 compound inheritance 
model of the disorder.
The Hypomorphic Risk Haplotype In Vitro
The TBX6 SNPs defining the haplotype for risk of 
congenital scoliosis could be functional or, alter-
natively, could be a composite genetic marker 
that is linked with the true functional variants. 
We conducted a linkage-disequilibrium analysis 
using common human SNPs22 and found that 
the linkage-disequilibrium block of TBX6 is short 
(5 kb by the four-gamete rule) (Fig. S4 in the 
Supplementary Appendix). We identified no rare 
mutation in this block. The most parsimonious 
explanation for this observation is that the com-
mon TBX6 SNPs defining the risk haplotype are 
functional.
The SNPs rs3809624 and rs3809627 are lo-
cated in the 5′ noncoding region of TBX6 (Fig. 
1B), potentially regulating TBX6 expression.29 
Data from the Encyclopedia of DNA Elements 
(ENCODE) Project suggest the possible involve-
ment of these two noncoding SNPs in the regu-
lation of gene expression.30 For example, both 
SNPs are located in the same binding site of up-
stream stimulatory factor 1 (USF1), a transcription 
factor potentially involved in somitogenesis.31,32
We used in vitro luciferase assays to study the 
effects of rs3809624 and rs3809627 on gene ex-
pression. Preliminary analyses in three human cell 
lines (HEK293, HepG2, and HeLa) showed signifi-
cant reductions in the expression of the reporter 
gene when linked to the portion of TBX6 harboring 
nonreference variants at both rs3809624 and 
rs3809627 (Fig. S5 and S6 in the Supplementary 
Appendix). We carried out the same experiment 
using the multipotent P19CL6 cells16,17 and 
hiPSCs. TBX6 was strongly expressed in these 
stem cells when they differentiated into meso-
dermal-cell lineages (Fig. S5 in the Supplemen-
tary Appendix). We observed that P19CL6 cells 
and hiPSCs carrying the luciferase reporter con-
struct with nonreference alleles at both rs3809624 
and rs3809627 expressed significantly less re-
porter protein on differentiation into mesoder-
mal and cardiac cells (Fig. 3A). These findings 
consistently support the hypomorphic effects 
of the combination of nonreference alleles at 
rs3809624 and rs3809627 on TBX6 expression.
Hemivertebrae in Persons with TBX6 -
Associated Congenital Scoliosis
To assess the influence of TBX6 disruption on the 
morphologic features of vertebral malformations, 
we evaluated the types of vertebral malformations 
in 23 persons with sporadic congenital scoliosis 
and TBX6 null mutations and in 204 persons with 
sporadic congenital scoliosis and no detected TBX6 
Table 2. Distribution of Cases of TBX6-Associated Congenital Scoliosis.
Series
No. of  
Patients
Cases of Congenital Scoliosis Explained  
by TBX6 Compound Inheritance P Value
percent
Series 1: patients with congenital scoliosis 161 11 <3.8×10−6*
Series 2: patients with congenital scoliosis 76 8 <8.4×10−4†
Series 3: patients with 16p11.2 deletion 42‡ 83 0.004§
* The P value was calculated on the basis of 17 of 161 patients with congenital scoliosis versus 0 of 166 controls.
† The P value was calculated on the basis of 6 of 76 patients with congenital scoliosis versus 0 of 166 controls.
‡ Six of 42 patients with 16p11.2 deletion had a congenital scoliosis phenotype.
§ The P value was calculated on the basis of 5 of 6 deletion carriers with congenital scoliosis versus 5 of 30 deletion carriers 
without scoliosis.
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nonsynonymous mutations. All 23 persons with 
TBX6-associated congenital scoliosis had one or 
more hemivertebrae (Table 1 and Fig. 2). The 
number of hemivertebrae was significantly high-
er in the persons with TBX6-associated congeni-
tal scoliosis than in those with congenital scolio-
sis but no apparent TBX6 mutation (P<0.001) 
(Table S8 in the Supplementary Appendix).
Discussion
The genetic basis for the risk of congenital sco-
liosis is poorly understood. The involvement of 
Tbx6 in vertebral malformations in mice has been 
suggested.4,25,33 However, a previous study involv-
ing 50 persons with congenital vertebral malfor-
mations identified no TBX6 mutations,5 and only a 
weak association between common TBX6 SNPs 
and congenital scoliosis in the Han Chinese pop-
ulation was reported previously.26 Our data show 
that TBX6 null mutations are associated with spo-
radic congenital scoliosis, and in conjunction with 
the TBX6 haplotype of T-C-A, these mutations ac-
counted for 8 to 11% of congenital scoliosis cas-
es in the study population with the disorder 
(Table 2). TBX6 null mutations and noncoding 
variants therefore contribute substantively to the 
complex trait of sporadic congenital scoliosis.
Generally, the molecular mechanism of human 
mendelian disorders associated with heterozy-
gous gene deletions or null mutations is haplo-
insufficiency, in which half the gene dosage is 
not sufficient for normal function.34,35 In con-
trast, the effect of diminished TBX6 dosage in 
congenital scoliosis is complex. We found that 
an additional TBX6 hypomorphic allele is required 
to cause a further decrement in gene-expression 
dosage beyond haploinsufficiency for penetrance 
of the congenital scoliosis phenotype (Fig. 3B).
A precedent for the mechanism of compound 
inheritance was provided by a recent study of hu-
man thrombocytopenia with absent radii (TAR) 
associated with the gene RBM8A in 1q21.1.36 The 
compound inheritance of TBX6 in congenital sco-
liosis, like that of RBM8A in TAR and analogous 
to a recessive trait, requires two mutant alleles at 
a genetic locus for trait manifestation. This model 
may also pertain to phenotypic variation and pen-
etrance of particular endophenotypes manifested 
in other genomic disorders that are associated 
with large-scale copy-number variants.37-39
The phenotypes of sporadic congenital scoli-
osis can be dramatically different. However, the 
23 persons whom we found to have TBX6-asso-
ciated congenital scoliosis were phenotypically 
consistent with one another, having one or more 
hemivertebrae. A heterozygous TBX6 stop-loss mu-
tation (p.*437Cext*81) was reported in a pedigree 
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Figure 3. Results of In Vitro Functional Assays of Common TBX6 Variants 
and the Mechanistic Model of TBX6-Associated Congenital Scoliosis.
Panel A shows the results of luciferase reporter assays. Two cell types 
(P19CL6 cells and human induced pluripotent stem cells [hiPSCs]) with 
high levels of expression of TBX6 during induced differentiation were used. 
The nonreference alleles of rs3809624 and rs3809627 are shown in blue, 
and the risk haplotype is underlined. At least three independent experiments 
of normalized luciferase activity were quantified, with the graph showing 
mean values and their standard errors (I bars). Panel B shows a simplified 
genetic model of TBX6-associated congenital scoliosis. TBX6 expression is 
critical for normal vertebral formation (the reference allele of TBX6 is indi-
cated by a black line). Heterozygous hypomorphic variants (shown in blue) 
cause only a moderate reduction in TBX6 expression. Even homozygous 
hypomorphic variants do not reduce TBX6 expression dramatically. Hetero-
zygous TBX6 null mutations (indicated by red brackets) may reduce gene 
expression by one half. Independently, these mutations hardly reach the 
gene-dosage threshold for congenital scoliosis. In combination, however, 
a null allele and a hypomorphic allele of TBX6 cause further reductions in 
gene expression that may confer a high risk of congenital scoliosis.
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with dominantly inherited spondylocostal dysos-
tosis, a specific group of vertebral abnormalities 
characterized by multiple segmentation defects 
of the vertebrae, malalignment of the ribs (though 
often with a symmetric thoracic cage), and non-
progressive scoliosis.40,41 Functional studies 
showed that this mutation caused partial re-
duction in the ability of TBX6 to activate tran-
scription.41 We further analyzed this previously 
reported pedigree and found that this TBX6 
stop-loss mutation was located within the T-C-A 
risk haplotype. The combined reduction in 
TBX6 expression and transcriptional activation 
might therefore account for spondylocostal dys-
ostosis in this family. Alternatively, the 81 ami-
no acids added to the C-terminal may affect the 
ability of TBX6 to interact with other proteins 
that are critical in vertebral formation, such as 
MESP2 and RIPPLY2.42,43
Environmental factors could also contribute 
to the variety of phenotypes of TBX6-associated 
congenital scoliosis. Mouse embryos are suscep-
tible to gestational hypoxia, and developmental 
processes such as somitogenesis are affected by 
cellular hypoxia.4,44 Moreover, gene–environment 
interactions can affect the penetrance of vertebral 
phenotypes in mouse embryos that are geneti-
cally predisposed to vertebral defects. Similar 
mechanisms could affect the phenotypes of 
persons with variants in and deletions of TBX6.4
Our data suggest that TBX6 mutations are a 
common genetic cause of congenital scoliosis in 
the populations from which we drew our sam-
ples. Our finding that compound inheritance of 
a rare TBX6 null mutation and a common risk 
haplotype causes congenital scoliosis will enable 
the molecular diagnosis of the disorder and ge-
netic counseling for some persons who have or 
are at risk for congenital scoliosis.
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